High-throughput Genetic Clustering of Type 2 Diabetes Loci Reveals Heterogeneous Mechanistic Pathways of Metabolic Disease
Hyunkyung KimiD, Kenneth E. WestermaniD, Kirk SmithiD, Joshua ChiouiD, Joanne B. ColeiD, Timothy D. MajarianiD, Marcin von GrotthussiD, Soo Heon KwakiD, Jaegil KimiD, Josep Maria MercaderiD, José C. FloreziD, Kyle J. GaultoniD, Alisa Knodle ManningiD, Miriam S. UdleriD
Abstract
Aims/hypothesisType 2 diabetes (T2D) is highly polygenic and influenced by multiple biological pathways. Rapid expansion in the number of T2D loci can be leveraged to identify such pathways, thus facilitating improved disease management. MethodsWe developed a high-throughput pipeline to enable clustering of T2D loci based on variant-trait associations. Our pipeline extracted summary statistics from genome-wide association studies (GWAS) for T2D and related traits to generate a matrix of 324 variant x 64 trait associations and applied Bayesian Non-negative Factorization (bNMF) to identify genetic components of T2D. We generated cluster-specific polygenic scores and performed regression analysis in an independent cohort (N=25,419) to assess for clinical relevance. ResultsWe identified ten clusters, replicating the five from our prior analysis as well as novel clusters related to beta-cell dysfunction, pronounced insulin secretion, and levels of alkaline phosphatase, lipoprotein-A, and sex hormone-binding globulin. Four clusters related to mechanisms of insulin deficiency, five to insulin resistance, and one had an unclear mechanism. The clusters displayed tissue-specific epigenomic enrichment, notably with the two beta-cell clusters differentially enriched in functional and stressed pancreatic beta-cell states. Additionally, cluster-specific polygenic scores were differentially associated with patient clinical characteristics and outcomes. The pipeline was applied to coronary artery disease and chronic kidney disease, identifying multiple shared genetic pathways with T2D. Conclusions/interpretationOur approach stratifies T2D loci into physiologically meaningful genetic clusters associated with distinct tissues and clinical outcomes. The pipeline allows for efficient updating as additional GWAS become available and can be readily applied to other conditions, facilitating clinical translation of GWAS findings. Software to perform this clustering pipeline is freely available.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 91
- FWCI
- 10.55
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clustering of Type 2 Diabetes Genetic Loci by Multi-Trait Associations Identifies Disease Mechanisms and Subtypes
Miriam S. Udler, Jaegil Kim, … José C. Florez·bioRxiv·May 11, 2018
- Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications
Suzuki Ken, Konstantinos Hatzikotoulas, … H. Janaka de Silva·Yearbook of pediatric endocrinologyPeer-reviewed·Sep 8, 2023
- A multi-omic integrative scheme characterizes tissues of action at loci associated with type 2 diabetes
Jason Torres, Moustafa Abdalla, … Mark I. McCarthy·The American Journal of Human GeneticsPeer-reviewed·Nov 12, 2020
- Novel susceptibility loci and genetic regulation mechanisms for type 2 diabetes
Angli Xue, Yang Wu, … Jian Yang·Nature CommunicationsPeer-reviewed·Jul 23, 2018
- Multi-ancestry Polygenic Mechanisms of Type 2 Diabetes Elucidate Disease Processes and Clinical Heterogeneity
Kirk Smith, Aaron J. Deutsch, … Miriam S. Udler·medRxiv·Sep 28, 2023
- Identification of type 2 diabetes loci in 433,540 East Asian individuals
Cassandra Nichole Spracklen, Momoko Horikoshi, … Kyong Soo Park·NaturePeer-reviewed·May 6, 2020